seeks to reveal the clinical parameters associated with suicidal ideation.
Material and Methods

Patients
Our sample comprised 93 schizophrenia patients (69% men, 31% women) consecutively admitted to Eginition Hospital, Department of Psychiatry, University of Athens, between October 1996 and November 1997. All patients and their relatives provided informed consent to participate in the study.
The patients were given a diagnosis according to DSM-IV criteria (6) by 2 independent psychiatrists with similar levels of education and experience. These diagnoses were reviewed on the day of discharge; all information collected during the inpatient period was taken into account. The patients' mean age was 30.3 years (SD 8.9). They had a mean of 12.3 years (SD 2.5) of education and a mean duration of illness of 7.2 years (SD 7.5). We excluded from the study patients with any other diagnosis on Axis I of DSM-IV, with current alcohol or drug abuse, with serious physical (especially neurological) illness, or with mental retardation. At the time of assessment, the patients were receiving the following medications: antipsychotic drugs (76%), antiparkinsonian agents (56%), anxiolytics (51%), antidepressants (14%), and mood stabilizers (2%).
Of the patients taking antipsychotic drugs, 63% used conventional antipsychotics, 19% used an atypical antipsychotic as monotherapy, and 18% used atypical antipsychotics concurrently with conventional antipsychotics. It should be noted that all patients taking antidepressants belonged to the depressed-suicidal group.
Measures
We assessed patients on admission (during the first week), using the Calgary Depression Scale for Schizophrenia (CDSS; 7, 8) , the Positive and Negative Syndrome Scale (PANSS; 9,10), the Rating Scale for Extrapyramidal Side Effects (RSESE; 11), the Barnes Rating Scale for DrugInduced Akathisia (BARS; 12), and the Abnormal Involuntary Movement Scale (AIMS; 13).
The CDSS is considered a specific, reliable, and valid measure of depression in schizophrenia. It comprises 9 items selected from the Hamilton Depression Rating Scale (HDRS) and the Present State Examination (PSE) and assesses symptoms of depression at any stage of the disease. Each item has a 4-choice response format (0 to 3). The total possible score is between 0 and 27.
Three psychiatrist-raters trained in the use of the instruments evaluated patients within a period of a few hours. The first rater assessed depressive symptomatology, using the CDSS, and akathisia, using the BARS. The second independent rater assessed positive symptoms, negative symptoms, and general psychopathology, using the PANSS, and extrapyramidal symptoms, using the RSESE. The third rater assessed abnormal involuntary movements, using the AIMS. A standardized data schedule that included social, clinical, and pharmacologic parameters was completed for each patient.
Reported suicidal thoughts and attempts were derived from the CDSS item 8 ("suicidality"). The ratings were as follows: 0 = absent; 1 = frequent thoughts of being better off dead or occasional thoughts of suicide; 2 = deliberately considered suicide with a plan, but made no attempt; 3 = suicide attempt apparently designed to end in death.
Statistical Methods
Schizophrenia patients rating 1 or more on the CDSS item "suicidality" (Group A; n = 19, mean age 31.3 years) were compared on many social and clinical parameters with schizophrenia patients matched for age and sex and scoring 0 on the same item (Group B; subjects without suicidal thoughts, n = 19, mean age 31.2 years). We used Wilcoxon matched pairs signed-rank tests and paired t tests when appropriate.
Because clinical symptoms potentially associated with suicidal thoughts are interrelated, we performed stepwise multiple regression analyses to assess their independent effect on suicidal ideation. We included all PANSS and CDSS items in the regression analysis. Statistical significance was set at P £ 0.05. Values are expressed as mean (SD). Data were analyzed with the Statistical Package for Social Sciences (SPSS) (14) .
Results
Of the patients, 20.4% reported any suicidal thought during the last 15 days; 11.8% reported frequent thoughts of being better off dead or occasional thoughts of suicide; and 6.4% reported deliberate suicide with a plan but made no attempt. Two subjects (2.2%) had attempted suicide during the last 15 days. All subjects reported both the more intense and the less intense suicidal feelings. Table 1 compares schizophrenia patients with suicidal thoughts with those without suicidal thoughts in terms of the severity of psychopathological parameters and motor side effects. In all parameters, there were no significant differences between the 2 matched groups of patients, with 1 exception: patients with suicidal thoughts scored higher than control subjects on the CDSS (10.52 vs 3.52, P < 0.0001).
There were no statistically significant differences between Group A and Group B patients in many social and clinical parameters, that is, in marital status (single, 84% vs 95%), education (years of schooling, 12.1 vs 13.2), employment status (unemployed, 79% vs 74%), duration of illness (years, 4. Stepwise multiple regression analyses revealed that the following scores predicted the patients' suicidality: on the PANSS, the items "depression" ($ = 0.408, P < 0.01), "guilt feelings" ($ = 0.402, P < 0.008), and "motor retardation" ($ = 0.369, P = 0.01); and on the CDSS, the items "pathological guilt" ($ = 0.603, P < 0.001) and "self-depreciation" ($ = 0.513, P < 0.01).
Discussion
To our knowledge, this is the first report on the prevalence and characteristics of inpatients with acute schizophrenia and suicidal thoughts that uses the CDSS, a specific instrument for assessing aspects of depression in schizophrenia. Until now several scales, such as the HDRS, have been used to estimate the depressive symptomatology of schizophrenia patients. However, all these scales have been standardized only for patients suffering from depression (15) (16) (17) (18) .
Limitations of this study include the relatively small sample of patients and the basing of suicidal ideation rating on the CDSS "suicidality" item, which was included in the calculation of the total depression score. However, the validity of the results is supported by the multivariate statistical methods used, as well as by the established reliability of the rating of depressive symptoms in schizophrenia patients.
According to our findings, suicidal thoughts are frequent among inpatients with acute schizophrenia. Recent suicidal ideation was reported by 20.4% of the entire group of patients, and 2.2% reported a suicide attempt in the 15 days before hospital admission.
Other authors have also reported high rates of suicidal thoughts among schizophrenia patients. Amador and others (19) pointed out that 22% of schizophrenia patients reported "yes" to the question of suicidal thoughts and behaviour in the past, while Dassori and others (20) reported that 32% of the schizophrenia patients in their sample exhibited death wishes with or without suicidal plans or attempts. Fenton and others (21) reported that 40% of the schizophrenia patients studied expressed suicidal ideation at some time during a 19-year follow-up, and Grave mentioned that, among patients with psychotic disorders, 30% were reported to have suicidal thoughts, threats, and (or) attempts before or during their index hospitalization (22) .
Risk factors for suicide in schizophrenia include several social and clinical parameters, such as young age, male sex, single and (or) unemployed status, having a high level of premorbid functioning, and having depression, severe psychopathology, previous suicide attempts, and multiple relapses (1,2,23-28 ).
There is, however, no information on risk factors for schizophrenia patients with suicidal thoughts. Moreover, there are few data regarding the relation between the presence of suicidal ideation and future suicidal behaviour. According to Funahashi and others, the presence of suicidal ideation was revealed as a predictor of suicide in their clinical investigation of 80 suicides by schizophrenia sufferers (29) . Conversely, Young and others reported that low levels of suicidal ideation may predict future suicidal behaviour better than depressed mood (30) . Suicide has been described as a process of different stages, starting with thoughts of death and suicide and ending in self-inflicted death. Most efforts to prevent suicide have been directed to those who have already made an attempt. However, primary prevention should involve people with suicidal thoughts.
According to our study results, there is a close relation between suicidal ideation and the presence of depression, guilt feelings, pathological guilt, self-depreciation, and motor retardation. Although most suicide ideators tend not to go through subsequent steps in the suicidal process, prevention of suicidal behaviours in schizophrenia patients should probably focus on reducing depressive and guilt feelings and on helping the individual to enhance self-esteem.
Our study focused on describing the clinical characteristics of inpatients with acute schizophrenia and suicidal ideation. The degree to which these characteristics represent risk factors relevant to future suicide behaviours remains unknown. A long-term follow-up study could provide an answer to this crucial question.
Résumé : Idéation suicidaire chez les patients hospitalisés souffrant de schizophrénie aiguë
Objectif : La schizophrénie est associée à un taux de suicide élevé. Cette étude examine la prévalence de l'idéation suicidaire dans une population de patients hospitalisés souffrant de schizophrénie aiguë et les paramètres cliniques associés aux idées suicidaires.
Méthode : Nous avons évalué 93 patients schizophrènes. Nous avons assorti des sujets selon l'âge et le sexe, et comparé les sujets avec et sans idées suicidaires. Nous avons exécuté une analyse de régression multiple par degrés pour évaluer l'association entre les symptômes cliniques spécifiques et l'idéation suicidaire.
Résultats :
Parmi les patients, 20,4 % ont déclaré avoir eu des idées suicidaires au cours des 15 jours précédents. La gravité des symptômes dépressifs, le retard moteur, les sentiments de culpabilité, la culpabilité pathologique et l'autodépréciation prédisaient l'idéation suicidaire des patients.
Conclusions :
Les idées suicidaires sont fréquentes chez les patients hospitalisés souffrant de schizophrénie aiguë. La prévention du comportement suicidaire doit entre autres consister à aider les patients à améliorer leur estime de soi ainsi qu'à réduire la dépression et les sentiments de culpabilité.
